"Implantée à Coudekerque-Branche près de Dunkerque, la clinique de Flandre est un établissement médico-chirurgical privé de 121 lits . L’établissement intègre une activité de soins de suite et de réadaptation polyvalents de 30 lits. La clinique de Flandre traite de multiples spécialités où elle s’avère particulièrement performante."

During the past decade, Clinique de Flandre conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinique de Flandre" #1 sponsor was "Federation Francophone de Cancerologie Digestive" with 3 trials, followed by "ARCAGY/ GINECO GROUP" with 1 trials sponsored, "Centre Francois Baclesse" with 1 trials sponsored, "Centre Hospitalier Universitaire, Amiens" with 1 trials sponsored and "Centre Oscar Lambret" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinique de Flandre" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Association de Neuro-Oncologues d'Expression Francaise" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator and "Centre de traitement des données du Cancéropôle Nord-Ouest, Centre F. BACLESSE, Caen, France" with 1 trials as a collaborator. Other collaborators include 2 different institutions and companies that were collaborators in the rest 12 trials.

According to Clinical.Site data, the most researched conditions in "Clinique de Flandre" are "Breast Cancer" (2 trials), "Cancer" (2 trials), "Metastatic Colorectal Cancer" (2 trials), "Adenocarcinoma of the Gastroesophageal Junction" (1 trials) and "Adenocarcinoma of the Stomach" (1 trials). Many other conditions were trialed in "Clinique de Flandre" in a lesser frequency.

Most popular intervention types in "Clinique de Flandre" are "Drug" (5 trials), "Behavioral" (2 trials), "Combination Product" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "PLACEBO" (2 trials), "Aflibercept" (1 trials), "Avelumab" (1 trials) and "Capecitabine" (1 trials). Other intervention names were less common.

The vast majority of trials in "Clinique de Flandre" are 7 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Clinique de Flandre". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Clinique de Flandre, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinique de Flandre, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".